TARGETED RET MUTATION RESEARCH
Accutest LyoMorph-Q
RET Mutation Detection Kit
Cost-effective and highly sensitive qPCR kit including lyophilized inhibitor-tolerant reagent mix with multiplex allele-specific primer-probe mix for detection of the RET M918T mutation in cfDNA, FFPE-derived gDNA and gDNA.
*Nominal capacity before controls, repeats or invalid reactions. One multiplex primer/probe reaction is required per sample.
1 duplex qPCR reaction
duplex reaction
for RET M918T
reported study conditions
RET M918T
One LyoMorph-Q platform. A growing oncology portfolio.
LyoMorph-Q uses a lyophilized inhibitor-tolerant reagent mix with standardized chemistry and cycling conditions across compatible targeted mutation panels, allowing multiple assays to run together on the same 96-well qPCR plate. The expanding portfolio supports focused solid- and blood-cancer research using cfDNA, FFPE-derived gDNA and gDNA.
Common workflow
Combine compatible mutation panels on one plate to improve throughput and reduce separate runs.
Growing assay menu
Build a scalable targeted-testing menu across established solid- and blood-cancer research panels.
Custom assay development
Discuss bespoke targets and panel combinations, including feasibility and low-minimum-order options.
Oncology technical support
Jant and shard-dx™ can support instrument compatibility, assay selection, evaluation planning and technical review.
Accutest LyoMorph-Q oncology assays are powered by SHARD DIAGNOSTICS™ (Nottingham, England). All products are for Research Use Only and are not for use in diagnostic procedures.
Ultrasensitive RET research in one duplex reaction
The kit combines mutation-specific amplification for RET M918T with an endogenous RNase P internal control and a dPCR-quantified positive control. No separate preamplification or post-PCR mutation-detection step is required.
The duplex reaction uses the universal LyoMorph-Q mastermix and shared cycling profile, supporting integration alongside compatible mutation panels on the same 96-well plate.
Use familiar qPCR workflows
Simple to adopt by using your existing cycler and expertise.
Conserve limited samples
Supports inputs from 1 ng, with 5 ng or more recommended where available. Maximum input depends on sample type.
Reduce cold-chain burden
Lyophilized chemistry supports ambient shipping. Follow the current documentation for storage after receipt and reconstitution.
Simplify analysis
Fixed thresholding supports simplified analysis through enhanced specificity.
Built for focused RET M918T research
One duplex reaction detects RET M918T (c.2753T>C) in FAM with an endogenous RNase P internal control in HEX.
Low-copy RET M918T detection
RET M918T has a reported 95% limit of detection of three mutant copies at 0.01% VAF. Performance should be interpreted together with DNA input and absolute mutant-molecule availability.
low-copy detection
RET M918T
Specificity in the reported study conditions
No false-positive mutation calls were reported at the tested wild-type inputs:
Results describe the reported study conditions and do not guarantee that false positives are impossible in every sample or laboratory.
| Protein change / control | Sequence change | Reaction | Fluorophore | Reported 95% LoD |
|---|---|---|---|---|
| M918T | c.2753T>C | 1 | FAM | 3 copies • 0.01% VAF |
| RNase P internal control | Human DNA control | 1 | HEX | Not applicable |
From extracted DNA to an interpretable run
Extract and quantify
Prepare cfDNA, gDNA or FFPE-derived DNA and verify input concentration.
Reconstitute reagents
Rehydrate the lyophilized reagent mix with the specified buffer according to the current protocol.
Prepare the duplex reaction
Combine the RET M918T/RNase P primer-probe mix with the sample and appropriate controls.
Run and interpret
Use the specified cycling and analysis settings. The universal 45-cycle program is approximately 75 minutes.
RET mutation kit FAQs
Which RET variant is covered?
The kit detects RET M918T, corresponding to sequence change c.2753T>C at codon 918.
What is the reported limit of detection?
The reported 95% LoD is three mutant copies at 0.01% VAF for RET M918T.
Can compatible mutation panels run on the same plate?
Compatible LyoMorph-Q mutation panels use a universal mastermix and shared cycling profile, allowing multiple panels to run on the same 96-well qPCR plate. Instrument optics, fluorescence channels and each assay’s requirements must still be locally verified.
Which sample types are supported?
The RET assay supports cfDNA, FFPE-derived gDNA and gDNA. The minimum input is 1 ng, with 5 ng or more recommended where available. Maximum inputs are 30 ng cfDNA, 25 ng FFPE-derived gDNA and 100 ng gDNA.
Is the assay quantitative?
The kit is designed primarily for sensitive mutation screening, not absolute mutant copy-number quantification. Ct values should not be interpreted directly as mutant molecule counts.
How long is the PCR program?
The universal LyoMorph-Q cycling profile uses a 45-cycle, one-phase program completed in approximately 75 minutes on a standard 96-well qPCR cycler.
How is the kit shipped and stored?
The lyophilized kit supports ambient shipping. Follow the current product documentation for component-specific storage, reconstitution and stability requirements after receipt.
Is this RET workflow a fit for your laboratory?
Tell us your sample type, target requirements and qPCR instrument. Jant’s molecular team can help review compatibility, documentation and evaluation needs.


